Marina E. Emborg

6.0k total citations · 1 hit paper
96 papers, 4.6k citations indexed

About

Marina E. Emborg is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Marina E. Emborg has authored 96 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cellular and Molecular Neuroscience, 41 papers in Neurology and 35 papers in Molecular Biology. Recurrent topics in Marina E. Emborg's work include Parkinson's Disease Mechanisms and Treatments (32 papers), Neurological disorders and treatments (25 papers) and Nerve injury and regeneration (23 papers). Marina E. Emborg is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (32 papers), Neurological disorders and treatments (25 papers) and Nerve injury and regeneration (23 papers). Marina E. Emborg collaborates with scholars based in United States, Switzerland and France. Marina E. Emborg's co-authors include Shuang Yang, Ben Roitberg, Jeffrey H. Kordower, James E. Holden, Michael D. Taylor, Yaping Chu, Patrick Aebischer, Stéphane Palfi, Nicole Déglon and Philippe Hantraye and has published in prestigious journals such as Science, The Lancet and Nature Medicine.

In The Last Decade

Marina E. Emborg

93 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neurodegeneration Prevented by Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson's Disease

2000 1.0k citations Jeffrey H. Kordower, Marina E. Emborg et al. profile →

Peers

Countries citing papers authored by Marina E. Emborg

Since Specialization

Citations

This map shows the geographic impact of Marina E. Emborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina E. Emborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina E. Emborg more than expected).

Fields of papers citing papers by Marina E. Emborg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina E. Emborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina E. Emborg. The network helps show where Marina E. Emborg may publish in the future.

Co-authorship network of co-authors of Marina E. Emborg

This figure shows the co-authorship network connecting the top 25 collaborators of Marina E. Emborg. A scholar is included among the top collaborators of Marina E. Emborg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina E. Emborg. Marina E. Emborg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advantages and challenges of using allogeneic vs. autologous sources for neuronal cell replacement in Parkinson’s disease: Insights from non-human primate studies 2025 ·Brain Research Bulletin ·Marina E. Emborg, (unknown), Kevin A. D’Amour, (unknown), Lily Neumann, Ai Zhang, Howard J. Federoff	2
2	Position paper: leveraging non-human primate (NHP) specificities to accelerate Parkinson’s disease and ageing research 2025 ·npj Parkinson s Disease ·Erwan Bézard, Rozalyn M. Anderson, Romina Aron Badin, Hagai Bergman, Ashley Boehringer, Simon Borgognon, Marina E. Emborg, Jeffrey H. Kordower, Jiayi Li, (unknown), (unknown), Yoland Smith, Masahiko Takada, Jun Takahashi, Ryōsuke Takahashi, Benjamin Dehay	0
3	Quantification of early gait development: Expanding the application of Catwalk technology to an infant rhesus macaque model 2023 ·Journal of Neuroscience Methods ·(unknown), (unknown), (unknown), (unknown), Jens C. Eickhoff, (unknown), (unknown), (unknown), (unknown), (unknown), Ann M. Mitzey, (unknown), Michele L. Schotzko, Kristen A. Pickett, Nancy Schultz‐Darken, Marina E. Emborg, David H. O’Connor, Thaddeus G. Golos, Emma L. Mohr, Karla Ausderau	0
4	Evaluating depression- and anxiety-like behaviors in non-human primates 2023 ·Frontiers in Behavioral Neuroscience ·Karla Ausderau, Ricki J. Colman, (unknown), Nancy Schultz‐Darken, Marina E. Emborg	7
5	Efficient in vivo neuronal genome editing in the mouse brain using nanocapsules containing CRISPR-Cas9 ribonucleoproteins 2022 ·Biomaterials ·(unknown), Yuyuan Wang, (unknown), Kathy J. Snow, Stephen A. Murray, Cathleen Lutz, Viktoriya Bondarenko, (unknown), (unknown), Ruosen Xie, Dongdong Li, Yi Zhao, Matthew T. Flowers, Heather A. Simmons, Subhojit Roy, Krishanu Saha, Jon E. Levine, Marina E. Emborg, Shaoqin Gong	19
6	Effects of Cardiac Sympathetic Neurodegeneration and PPARγ Activation on Rhesus Macaque Whole Blood miRNA and mRNA Expression Profiles 2020 ·BioMed Research International ·(unknown), Mary S. Lopez, Jenna Kropp Schmidt, Megan E. Murphy, Raghu Vemuganti, Marina E. Emborg	2
7	Spatiotemporal quantification of gait in common marmosets 2019 ·Journal of Neuroscience Methods ·Kristen A. Pickett, Nancy Schultz‐Darken, (unknown), (unknown), (unknown), Karla Ausderau, Marina E. Emborg	4
8	In Vitro Modeling of Leucine-Rich Repeat Kinase 2 G2019S-Mediated Parkinson's Disease Pathology 2018 ·Stem Cells and Development ·Scott Vermilyea, Marina E. Emborg	4
9	Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Adult Common Marmoset Fibroblasts 2017 ·Stem Cells and Development ·Scott Vermilyea, (unknown), Michaël Meyer, Kim Smuga-Otto, Katarina M. Braun, Sara E. Howden, James A. Thomson, Su‐Chun Zhang, Marina E. Emborg, Thaddeus G. Golos	25
10	Overexpressing Corticotropin-Releasing Factor in the Primate Amygdala Increases Anxious Temperament and Alters Its Neural Circuit 2016 ·Biological Psychiatry ·Ned H. Kalin, Andrew S. Fox, Rothem Kovner, (unknown), Éva Fekete, Patrick H. Roseboom, Do Tromp, (unknown), (unknown), Ethan K. Brodsky, Daniel R. McFarlin, Andrew L. Alexander, Marina E. Emborg, Walter F. Block, Julie L. Fudge, Jonathan A. Oler	59
11	α-Synuclein and nonhuman primate models of Parkinson's disease 2015 ·Journal of Neuroscience Methods ·Scott Vermilyea, Marina E. Emborg	29
12	Titer and Product Affect the Distribution of Gene Expression after Intraputaminal Convection-Enhanced Delivery 2014 ·Stereotactic and Functional Neurosurgery ·Marina E. Emborg, Samuel A. Hurley, Valerie Joers, Do Tromp, Christine R. Swanson, (unknown), (unknown), (unknown), M.A.F. Sonnemans, Stephan Hermening, Bas Blits, Andrew L. Alexander	15
13	Induced Pluripotent Stem Cell-Derived Neural Cells Survive and Mature in the Nonhuman Primate Brain 2013 ·Cell Reports ·Marina E. Emborg, Yan Liu, Jiajie Xi, Xiaoqing Zhang, (unknown), Jianfeng Lü, Valerie Joers, Christine R. Swanson, James E. Holden, Su‐Chun Zhang	115
14	A Monoclonal Antibody-GDNF Fusion Protein Is Not Neuroprotective and Is Associated with Proliferative Pancreatic Lesions in Parkinsonian Monkeys 2012 ·PLoS ONE ·(unknown), Heather A. Simmons, (unknown), Valerie Joers, Christine R. Swanson, Viktoriya Bondarenko, (unknown), Kevin Brunner, Laura D. Wood, Ralph H. Hruban, Marina E. Emborg	56
15	Risk of surgical delivery to deep nuclei: A meta‐analysis 2011 ·Movement Disorders ·Jonathan Kimmelman, (unknown), Tim Ramsay, Tiffini Voss, Bernard Ravina, Marina E. Emborg	48
16	Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF 2009 ·Neurobiology of Disease ·Marina E. Emborg, Jeffrey M. Moirano, (unknown), Viktoriya Bondarenko, Romain Zufferey, (unknown), Allison D. Ebert, Valerie Joers, Ben Roitberg, J. E. Holden, James B. Koprich, Jack W. Lipton, Jeffrey H. Kordower, Patrick Aebischer	39
17	Mood, Memory and Movement: An Age-Related Neurodegenerative Complex? 2008 ·Current Aging Science ·Ann‐Charlotte Granholm, Heather A. Boger, Marina E. Emborg	32
18	The Effects of a Selective Dopamine D2 Receptor Agonist on Behavioral and Pathological Outcome in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Squirrel Monkeys 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Diane Stephenson, Martin D. Meglasson, Mark A. Connell, (unknown), Éva Hajós‐Korcsok, Marina E. Emborg	19
19	Evaluation of animal models of Parkinson's disease for neuroprotective strategies 2004 ·Journal of Neuroscience Methods ·Marina E. Emborg	121
20	Cell transplantation for Parkinson's disease 2004 ·Neurological Research ·Ben Roitberg, (unknown), Marina E. Emborg	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact